Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4255393 Title: FORMULATION TOPIQUE DE ROFLUMILAST PRÉSENTANT DES PROPRIÉTÉS ANTIFONGIQUES

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
218402428
WO application number:
US2021061871
Type:
European patent granted for BE
Status:
Open
Publication number:
4255393
WO publication number:
WO2022120213
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
03/12/2021
Grant date:
28/05/2025
EP publication date:
11/10/2023
WO publication date:
09/06/2022
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
28/05/2025
EP B1 publication date:
28/05/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
03/12/2041

Applicant

Name:
Arcutis Biotherapeutics, Inc.
Legal Form:
From:
28/05/2025
Address:
3027 Townsgate Road, Suite 300, Westlake Village, CA 91361, United States (US)
To:

Inventor

1

Name:
KATO, Saori
Legal Form:
Address:
Westlake Village, California 91361, United States (US)

2

Name:
BERK, David Reuben
Legal Form:
Address:
Westlake Village, California 91361, United States (US)

3

Name:
BURNETT, Patrick Eugene
Legal Form:
Address:
Westlake Village, California 91361, United States (US)

4

Name:
OSBORNE, David
Legal Form:
Address:
Fort Collins, Colorado 80525, United States (US)

Priority

Priority patent number:
202063121299 P
Priority date:
04/12/2020
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61K 31/137; A61K 9/00; A61K 31/201; A61K 31/343; A61K 31/4174; A61K 31/44; A61K 31/496; A61K 31/506; A61K 31/513; A61K 31/60; A61K 33/04; A61K 45/06; A61P 17/00; A61P 17/04; A61P 31/10; A61K 9/107; A61K 9/12;

Publication

European Patent Bulletin

Issue number:
202522
Publication date:
28/05/2025
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/01/2026
Annual fee number:
5
Annual fee amount:
75 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type